On April 12, 2023 CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related cancers, reported that the management team will participate in two upcoming investor conferences in April 2023 (Press release, CTI BioPharma, APR 12, 2023, View Source [SID1234629990]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

22nd Annual Needham Virtual Healthcare Conference
Type: Fireside Chat
Tuesday, April 18, 2023
3:45 p.m. ET (12:45 p.m. PT)

Stifel 2023 Targeted Oncology Days (Virtual)
Type: Corporate Presentation
Wednesday, April 26, 2023
1:00 p.m. ET (10:00 a.m. PT)

A link to the live and archived webcast may be accessed on the CTI BioPharma website under the Investors & Media section: Events and Presentations.

On April 12, 2023 Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, reported its participation in the following upcoming virtual investor conferences (Press release, Cogent Biosciences, APR 12, 2023, View Source [SID1234629989]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

22nd Annual Needham Healthcare Conference
Wednesday, April 19, 2023 at 2:15 p.m. ET

Stifel 2023 Targeted Oncology Days
Tuesday, April 25, 2023 at 12:30 p.m. ET

A live webcast of each event can be accessed on the Investors & Media page of Cogent’s website at View Source A replay of the webcasts will be available approximately two hours after the completion of the events and will be archived for up to 30 days.

On April 12, 2023 Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company focused on the discovery and development of innovative therapeutics for fibro-inflammatory diseases with high unmet need, reported the company will discuss its first quarter 2023 financial results and provide a corporate update on Thursday, May 11, 2023, at 8:00 am Eastern Time (Press release, Chemomab, APR 12, 2023, View Source [SID1234629988]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

This webcast and call replaces and supplements a previously announced Corporate Update event that had been scheduled for April 17, 2023.

During the event, Chemomab’s management team will review first quarter 2023 performance, discuss recent and upcoming developments and conduct a live question-and-answer session.

A replay of the webcast and call will be available on Chemomab’s website for 90 days at www.chemomab.com.

Live Webcast and Conference Call at 8:00 am Eastern Time, Thursday, May 11, 2023

Click this Webcast link to access the live webcast or replay.

The live webcast and replay can also be accessed at the News & Events section of the Investors page on the Chemomab website at investors.chemomab.com/events.

Conference Call Access via Telephone

US Investors: +1 (877) 407-9208
International Investors: +1 (201) 493-6784
Conference ID code: 13735393
Please call 5-10 minutes before the scheduled start time, enter the conference passcode and ask the operator for the Chemomab conference call.

Or click on Call meTM starting 15 minutes before the scheduled start time for instant telephone access without having to wait for an operator.

On April 12, 2023 BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) reported that the company will present at the following investor conferences (Press release, BioCryst Pharmaceuticals, APR 12, 2023, View Source [SID1234629987]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The 22nd Annual Needham Virtual Healthcare Conference on Wednesday, April 19th at 8:45 a.m. ET

The BofA Securities 2023 Health Care Conference in Las Vegas on Wednesday, May 10th at 6:00 p.m. ET

The JMP Securities Life Sciences Conference in New York on Tuesday, May 16th at 2:30 p.m. ET

The RBC Capital Markets Global Healthcare Conference in New York on Wednesday, May 17th at 8:00 a.m. ET

Links to the live audio webcasts and replays of the presentations may be accessed in the Investors & Media section of BioCryst’s website at http://www.biocryst.com.

On April 12, 2023 Bio-Techne Corporation (NASDAQ: TECH) reported that management will host a conference call and webcast on Wednesday, May 3, 2023, at 8:00 a.m. CDT to review third quarter 2023 financial results (Press release, Bio-Techne, APR 12, 2023, https://investors.bio-techne.com/news/detail/361/bio-techne-to-host-conference-call-on-may-3-2023-to-announce-third-quarter-2023-financial-results [SID1234629986]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Access to the discussion may be obtained as follows:

Time:

8:00 a.m. CDT

Date:

May 3, 2023

Dial-in:

1-877-300-8521 or 1-412-317-6026 (for international callers)

Conference ID:

10177426

Webcast:

View Source;tp_key=a481261dfe

A recorded rebroadcast will be available for interested parties unable to participate in the live conference call by dialing 1-844-512-2921 or 1-412-317-6671 (for international callers) and referencing Conference ID 10177426.

The replay will be available from 11:00 a.m. CDT on Wednesday, May 3, 2023, until 11:00 p.m. CDT on Saturday, June 3, 2023.